Delivery Order SPE2DB24D2205-SPE2DB25FEHED
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $1,211.69. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger federal contract portfolio...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,287.75 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor...
- The Defense Logistics Agency awarded a delivery order valued at $7,690.32 to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,192.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 mL syringes (2 mL quantity) on September 18, 2025, with completion scheduled for September 19, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,424.26. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizing firm fixed price pricing. This is a non-set-aside competitive award, and the place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters location. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $63,839.13 under a firm fixed price contract. This delivery order represents a competitive award with no set-aside designation and is expected to be completed by September 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $3,153.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of August 14, 2025, and performance to be executed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The product is a hyaluronic acid injection used for osteoarthritis management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $3,090.60 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by May 7, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,454.88 under a firm fixed-price contract. This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded without set-aside designation and will be performed at the...